315 related articles for article (PubMed ID: 26387544)
21. (alpha)v(beta)3 integrins and Pyk2 mediate insulin-like growth factor I activation of Src and mitogen-activated protein kinase in 3T3-L1 cells.
Sekimoto H; Eipper-Mains J; Pond-Tor S; Boney CM
Mol Endocrinol; 2005 Jul; 19(7):1859-67. PubMed ID: 15761030
[TBL] [Abstract][Full Text] [Related]
22. Potential crosstalk of the interleukin-6-heme oxygenase-1-dependent mechanism involved in resistance to lenalidomide in multiple myeloma cells.
Wu W; Ma D; Wang P; Cao L; Lu T; Fang Q; Zhao J; Wang J
FEBS J; 2016 Mar; 283(5):834-49. PubMed ID: 26700310
[TBL] [Abstract][Full Text] [Related]
23. Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.
Rolón-Reyes K; Kucheryavykh YV; Cubano LA; Inyushin M; Skatchkov SN; Eaton MJ; Harrison JK; Kucheryavykh LY
PLoS One; 2015; 10(6):e0131059. PubMed ID: 26098895
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
Revuelta-López E; Castellano J; Roura S; Gálvez-Montón C; Nasarre L; Benitez S; Bayes-Genis A; Badimon L; Llorente-Cortés V
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2877-87. PubMed ID: 24072693
[TBL] [Abstract][Full Text] [Related]
25. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
[TBL] [Abstract][Full Text] [Related]
27. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells.
Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB
Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439
[TBL] [Abstract][Full Text] [Related]
28. Imipramine administration induces changes in the phosphorylation of FAK and PYK2 and modulates signaling pathways related to their activity.
Zalewska T; Bielawski A; Stanaszek L; Wieczerzak K; Ziemka-Nałęcz M; Nalepa I
Biochim Biophys Acta; 2016 Feb; 1860(2):424-33. PubMed ID: 26620976
[TBL] [Abstract][Full Text] [Related]
29. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
[TBL] [Abstract][Full Text] [Related]
30. Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.
Katsume A; Okigaki M; Matsui A; Che J; Adachi Y; Kishita E; Yamaguchi S; Ikeda K; Ueyama T; Matoba S; Yamada H; Matsubara H
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1084-92. PubMed ID: 21372295
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
Park S; Lee HJ; Jeong SJ; Song HS; Kim M; Lee HJ; Lee EO; Kim DH; Ahn KS; Kim SH
Food Chem Toxicol; 2011 Jun; 49(6):1367-72. PubMed ID: 21420464
[TBL] [Abstract][Full Text] [Related]
32. Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma.
Kudo C; Yamakoshi H; Sato A; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
Anticancer Res; 2011 Nov; 31(11):3719-26. PubMed ID: 22110192
[TBL] [Abstract][Full Text] [Related]
33. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
34. PYK2 is an adhesion kinase in macrophages, localized in podosomes and activated by beta(2)-integrin ligation.
Duong LT; Rodan GA
Cell Motil Cytoskeleton; 2000 Nov; 47(3):174-88. PubMed ID: 11056520
[TBL] [Abstract][Full Text] [Related]
35. Recognition of LD motifs by the focal adhesion targeting domains of focal adhesion kinase and proline-rich tyrosine kinase 2-beta: Insights from molecular dynamics simulations.
Michael E; Polydorides S; Promponas VJ; Skourides P; Archontis G
Proteins; 2020 Aug; ():. PubMed ID: 32776636
[TBL] [Abstract][Full Text] [Related]
36. The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells.
Monaghan KA; Khong T; Burns CJ; Spencer A
Leukemia; 2011 Dec; 25(12):1891-9. PubMed ID: 21788946
[TBL] [Abstract][Full Text] [Related]
37. Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
Lyu A; Humphrey RS; Nam SH; Durham TA; Hu Z; Arasappan D; Horton TM; Ehrlich LIR
Nat Commun; 2023 Oct; 14(1):6270. PubMed ID: 37805579
[TBL] [Abstract][Full Text] [Related]
38. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2.
Lee SH; Yun S; Piao ZH; Jeong M; Kim DO; Jung H; Lee J; Kim MJ; Kim MS; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I
J Immunol; 2010 Jul; 185(2):917-28. PubMed ID: 20543098
[TBL] [Abstract][Full Text] [Related]
39. An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2.
Meirson T; Samson AO; Gil-Henn H
Drug Des Devel Ther; 2017; 11():1535-1557. PubMed ID: 28572720
[TBL] [Abstract][Full Text] [Related]
40. Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity.
Fan H; Guan JL
J Biol Chem; 2011 May; 286(21):18573-82. PubMed ID: 21471206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
